Youssef Bennani
Managing Partner at CTI Life Sciences Fund- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
French Native or bilingual proficiency
-
Arabic Native or bilingual proficiency
-
Italian Limited working proficiency
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
CTI Life Sciences Fund
-
Canada
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Managing Partner
-
May 2021 - Present
-
-
Managing Partner-CTI Life Sciences
-
May 2021 - Present
-
-
-
Bellus Health
-
Canada
-
Biotechnology Research
-
1 - 100 Employee
-
Board Member
-
Apr 2017 - Present
-
-
-
adMare BioInnovations
-
Canada
-
Biotechnology Research
-
100 - 200 Employee
-
CSO at AdMare BioInnovations-ex-Board member
-
Feb 2020 - Present
-
-
Venture Partner-adMare BioInnovations
-
Apr 2019 - Feb 2020
-
-
-
-
Pharmaceutical Executive
-
Mar 2018 - Present
-
-
-
DOMAIN Therapeutics
-
France
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Chairman of the Board of Directors at Domain Therapeutics
-
Apr 2014 - Apr 2023
-
-
-
Find Therapeutics
-
Canada
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
May 2020 - Feb 2022
-
-
-
Independant
-
Movies, Videos, and Sound
-
100 - 200 Employee
-
Board Of Directors
-
Apr 2014 - May 2019
-
-
-
Vertex Pharmaceuticals
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Site Head & VP R&D
-
Dec 2012 - Mar 2018
Site Management, Government relationship, R&D leadership
-
-
Vice-President Drug Innovation
-
Sep 2004 - Dec 2012
-
-
Vice-President-Drug Innovation
-
Sep 2004 - Aug 2011
Worked on Antivirals (HCV, Flu, HSV), Antibiotics, Inflammation, Oncology and CNS targets
-
-
-
Athersys
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Sr. Director-Medicinal Chemistry
-
May 2001 - Aug 2004
Worked on building a company, and researched on immunology, oncology and obesity targets Worked on building a company, and researched on immunology, oncology and obesity targets
-
-
-
Abbott
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Sr. Group Leader
-
1996 - 2001
Worked on metabolic, infectious and CNS conditions Worked on metabolic, infectious and CNS conditions
-
-
-
Ligand Pharmaceuticals
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Research Scientist
-
1993 - 1996
Researched on metabolic and anti-cancer medicines Researched on metabolic and anti-cancer medicines
-
-
-
TSRI
-
United States
-
Research scientist
-
1991 - 1993
Worked on the Catalytic Asymmetric Dihydroxylation reaction, under K. B. Sharpless Worked on the Catalytic Asymmetric Dihydroxylation reaction, under K. B. Sharpless
-
-
Education
-
UdeM, McGill, LFGSM
PhD, MBA, ICD.D, Medicinal and Pharmaceutical Chemistry, Business, Corporate Governance -
McGill University
Institute of Corporate Directors-D, Businees -
Lake Forest Graduate School of Management
PhD (UofM) & MBA, General -
The Scripps Research Institute
Post-doc, Organic Chemistry -
Université de Montréal
PhD, Chemistry -
UdeM, McGill, LFGSM
PhD, MBA, ICD.D, Chemitry, Business, Governance